"NAME";"PROBE";"GENE SYMBOL";"GENE TITLE";"RANK IN GENE LIST";"RANK METRIC SCORE";"CORE ENRICHMENT"
"row_0";"ENSG00000105810";"CDK6";"cyclin dependent kinase 6";1331;5,61125183105469;"No"
"row_1";"ENSG00000110092";"CCND1";"cyclin D1";1902;3,09610533714294;"No"
"row_2";"ENSG00000146648";"EGFR";"epidermal growth factor receptor";2025;2,77229332923889;"No"
"row_3";"ENSG00000100485";"SOS2";"SOS Ras/Rho guanine nucleotide exchange factor 2";2734;1,57764029502869;"No"
"row_4";"ENSG00000171608";"PIK3CD";"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta";2804;1,47959756851196;"No"
"row_5";"ENSG00000142208";"AKT1";"AKT serine/threonine kinase 1";3054;1,134153008461;"No"
"row_6";"ENSG00000117020";"AKT3";"AKT serine/threonine kinase 3";3225;1,0194057226181;"No"
"row_7";"ENSG00000105851";"PIK3CG";"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma";3400;0,89727383852005;"No"
"row_8";"ENSG00000124181";"PLCG1";"phospholipase C gamma 1";4101;0,837056875228882;"No"
"row_9";"ENSG00000118689";"FOXO3";"forkhead box O3";4200;0,762314021587372;"No"
"row_10";"ENSG00000154229";"PRKCA";"protein kinase C alpha";4563;0,567452907562256;"No"
"row_11";"ENSG00000139687";"RB1";"RB transcriptional corepressor 1";5018;0,402504056692123;"No"
"row_12";"ENSG00000133703";"KRAS";"KRAS proto-oncogene, GTPase";5032;0,396901160478592;"No"
"row_13";"ENSG00000126583";"PRKCG";"protein kinase C gamma";5245;0,335710972547531;"No"
"row_14";"ENSG00000145675";"PIK3R1";"phosphoinositide-3-kinase regulatory subunit 1";5442;0,294857949018478;"No"
"row_15";"ENSG00000115904";"SOS1";"SOS Ras/Rac guanine nucleotide exchange factor 1";5815;0,219680368900299;"No"
"row_16";"ENSG00000213281";"NRAS";"NRAS proto-oncogene, GTPase";5947;0,194634199142456;"No"
"row_17";"ENSG00000186350";"RXRA";"retinoid X receptor alpha";6528;0,12797811627388;"No"
"row_18";"ENSG00000112242";"E2F3";"E2F transcription factor 3";6844;0,0984350517392159;"No"
"row_19";"ENSG00000157764";"BRAF";"B-Raf proto-oncogene, serine/threonine kinase";6893;0,0936987474560738;"No"
"row_20";"ENSG00000101412";"E2F1";"E2F transcription factor 1";7039;0,0803907439112663;"No"
"row_21";"ENSG00000121879";"PIK3CA";"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha";7188;0,0722698718309402;"No"
"row_22";"ENSG00000068028";"RASSF1";"Ras association domain family member 1";7809;0,0352056287229061;"No"
"row_23";"ENSG00000177885";"GRB2";"growth factor receptor bound protein 2";8197;0,021698011085391;"No"
"row_24";"ENSG00000002330";"BAD";"BCL2 associated agonist of cell death";9034;0,00313815544359386;"No"
"row_25";"ENSG00000105647";"PIK3R2";"phosphoinositide-3-kinase regulatory subunit 2";9448;0,000175316163222305;"No"
"row_26";"ENSG00000117461";"PIK3R3";"phosphoinositide-3-kinase regulatory subunit 3";10020;0;"No"
"row_27";"ENSG00000143171";"RXRG";"retinoid X receptor gamma";10516;0;"No"
"row_28";"ENSG00000126934";"MAP2K2";"mitogen-activated protein kinase kinase 2";27649;-2,10201210393279e-06;"No"
"row_29";"ENSG00000135446";"CDK4";"cyclin dependent kinase 4";27835;-0,000540289038326591;"No"
"row_30";"ENSG00000140992";"PDPK1";"3-phosphoinositide dependent protein kinase 1";27897;-0,000833478756248951;"No"
"row_31";"ENSG00000101109";"STK4";"serine/threonine kinase 4";28306;-0,00491573428735137;"No"
"row_32";"ENSG00000141510";"TP53";"tumor protein p53";28450;-0,00730912433937192;"No"
"row_33";"ENSG00000132155";"RAF1";"Raf-1 proto-oncogene, serine/threonine kinase";28502;-0,00834258366376162;"No"
"row_34";"ENSG00000132906";"CASP9";"caspase 9";28731;-0,0131363142281771;"No"
"row_35";"ENSG00000051382";"PIK3CB";"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta";30914;-0,148309290409088;"No"
"row_36";"ENSG00000077092";"RARB";"retinoic acid receptor beta";31124;-0,176122665405273;"No"
"row_37";"ENSG00000105221";"AKT2";"AKT serine/threonine kinase 2";31147;-0,179927334189415;"No"
"row_38";"ENSG00000102882";"MAPK3";"mitogen-activated protein kinase 3";31469;-0,227050453424454;"No"
"row_39";"ENSG00000100030";"MAPK1";"mitogen-activated protein kinase 1";32136;-0,355675846338272;"No"
"row_40";"ENSG00000169032";"MAP2K1";"mitogen-activated protein kinase kinase 1";32238;-0,381089836359024;"No"
"row_41";"ENSG00000078061";"ARAF";"A-Raf proto-oncogene, serine/threonine kinase";32267;-0,394005656242371;"No"
"row_42";"ENSG00000189283";"FHIT";"fragile histidine triad diadenosine triphosphatase";33431;-1,02751708030701;"No"
"row_43";"ENSG00000007968";"E2F2";"E2F transcription factor 2";34111;-1,37592339515686;"No"
"row_44";"ENSG00000204231";"RXRB";"retinoid X receptor beta";34807;-2,9657735824585;"Yes"
"row_45";"ENSG00000141736";"ERBB2";"erb-b2 receptor tyrosine kinase 2";35275;-5,20894718170166;"Yes"
"row_46";"ENSG00000174775";"HRAS";"HRas proto-oncogene, GTPase";35357;-5,74726963043213;"Yes"
"row_47";"ENSG00000163235";"TGFA";"transforming growth factor alpha";35510;-6,9935736656189;"Yes"
"row_48";"ENSG00000266094";"RASSF5";"Ras association domain family member 5";35763;-10,7071542739868;"Yes"
"row_49";"ENSG00000141506";"PIK3R5";"phosphoinositide-3-kinase regulatory subunit 5";35771;-10,9088764190674;"Yes"
"row_50";"ENSG00000197943";"PLCG2";"phospholipase C gamma 2";35901;-13,6591892242432;"Yes"
"row_51";"ENSG00000147889";"CDKN2A";"cyclin dependent kinase inhibitor 2A";35903;-13,7895994186401;"Yes"
"row_52";"ENSG00000138798";"EGF";"epidermal growth factor";36025;-18,1960105895996;"Yes"
"row_53";"ENSG00000166501";"PRKCB";"protein kinase C beta";36360;-55,8752517700195;"Yes"
